Cardio Diagnostics Holdings, Inc. (CDIOW)
CDIOWNASDAQ-CMBiotechnology: In Vitro & In Vivo Diagnostic Substances
$0.00960000
0.0000 (0.00%) today
Pre-market, Nov 17, 10:47 AM ET
- Market cap
- $16.6k
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- –
- 52-week range
- $0.00520000 to $0.0721
- Average volume
- –
- Previous close
- $0.00960000
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $4,000 | $3,000 | $5,000 | $4,000 |
| Gross profit | $4,000 | $3,000 | $5,000 | $4,000 |
| Operating income | -$1.46m | -$1.78m | -$1.50m | -$1.73m |
| Net income | -$1.47m | -$1.79m | -$1.50m | -$1.73m |
Last four quarters: revenue $16.0k, margin -40537.5%, free cash flow –
News
8 latest- Trulieve Was the First U.S. Pure-Play Cannabis Stock on the NYSE. Here's Which Stock Could Be Next.The Motley Fool · 17 minutes ago
- A SpaceX-Tesla Merger Needs "Yes" From 50% of All Tesla Shares, Not Just Votes Cast. Here's Why That Math Is Harder Than Wall Street Thinks.The Motley Fool · 23 minutes ago
- Amazon vs. Alphabet: Which Cloud Computing Stock Is the Better Buy?The Motley Fool · 37 minutes ago
- IonQ’s Platform Revenue Grew 127%. Is the Stock a Buy?The Motley Fool · 40 minutes ago
- Nvidia Has Lost More Than the Market Value of 495 S&P 500 Companies in 6 Weeks -- and Its Downtrend May Be Just BeginningThe Motley Fool · 1 hour ago
- Yesway Prices Secondary Offering Of 5 Mln Shares At $19 Per Share RTTNews · 1 hour ago
- AppLovin Stock Is Up 39% in a Month: Is The Stock Still a Buy?The Motley Fool · 1 hour ago
- Warren Buffett’s Successor Just Bought $10 Billion of This AI Stock, and It’s Not AppleThe Motley Fool · 1 hour ago
The company
Cardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The Company was formed to further develop and commercialize clinical tests by leveraging a proprietary Artificial Intelligence (AI)-driven Integrated Genetic-Epigenetic Engine ('Core Technology') for cardiovascular disease.
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- cdio.ai
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.